A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD
- Status
- COMPLETED
- Phase
- PHASE1
Study of INCB053914 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
- Status
- TERMINATED
- Phase
- PHASE2
Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Ruxolitinib in Combination With Autotransplant
- Status
- WITHDRAWN
- Phase
- NA
INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/Refractory Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2